VANI

Vivani Medical, Inc. Common Stock (DE)

1.27

USD

VANI Earnings Reports

Positive Surprise Ratio

VANI beat 14 of 27 last estimates.

52%

Next Report

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.10

Implied change from Q3 25 (Revenue/ EPS)

-9.09%

Implied change from Q4 24 (Revenue/ EPS)

-9.09%

Vivani Medical, Inc. Common Stock (DE) earnings per share and revenue

On Nov 13, 2025, VANI reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.44% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an decrease of -9.09% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Vivani Medical, Inc. Common Stock (DE)'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Vivani Medical, Inc. Common Stock (DE) reported EPS of -$0.11, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.

How did the market react to Vivani Medical, Inc. Common Stock (DE)'s Q3 2025 earnings?

The stock price moved down -11.44%, changed from $1.53 before the earnings release to $1.35 the day after.

When is Vivani Medical, Inc. Common Stock (DE) expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Vivani Medical, Inc. Common Stock (DE)'s next earnings report?

Based on 4 analysts, Vivani Medical, Inc. Common Stock (DE) is expected to report EPS of -$0.10 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.